GHK Peptide, Urocanic Acid, and Copper Form New Physiological Complex
Background
The tripeptide GHK (Gly-His-Lys), cis-urocanic acid (cis-UCA), and Cu(II) ions are naturally occurring components found in human tissues like the skin and plasma. While GHK is well-established as a Cu(II)-binding molecule with various biological effects, the potential for cis-UCA to also coordinate Cu(II), and more importantly, whether these two ligands can form a ternary complex with Cu(II) in physiological settings, remained unexplored.
Results
The study definitively confirmed that cis-urocanic acid is indeed capable of coordinating Cu(II) ions, establishing it as a novel copper-binding ligand. Crucially, the researchers successfully identified and characterized the formation of a stable ternary Cu(II) complex involving all three components: GHK, cis-UCA, and Cu(II), demonstrating their simultaneous interaction. This newly identified [GHK][Cu(II)][cis-urocanic acid] ternary complex is likely a physiologically relevant species, given the natural concentrations and reported affinities of its constituents in human tissues like skin and plasma. The formation of this complex suggests a novel mechanism by which GHK and cis-UCA might exert their known biological effects, potentially by modulating Cu(II) availability and activity. This finding provides a deeper understanding of Cu(II) homeostasis and the intricate interactions of these biomolecules.
Why It Matters
This research significantly advances our understanding of how GHK and cis-urocanic acid function within the human body, particularly concerning their interactions with copper. The discovery of the [GHK][Cu(II)][cis-urocanic acid] ternary complex provides a novel mechanistic explanation for some of the previously observed biological effects of both GHK and urocanic acid, such as their roles in skin regeneration or UV protection. Future research could explore the therapeutic potential of this specific ternary complex in conditions related to copper dysregulation or skin health, potentially leading to new cosmetic or dermatological applications. This warrants further investigation through in vivo studies and potentially preclinical development.